Twin Peaks Wealth Advisors, LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Twin Peaks Wealth Advisors, LLC
- $309 Billion
- Q2 2025
A detailed history of Twin Peaks Wealth Advisors, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Twin Peaks Wealth Advisors, LLC holds 49 shares of ARWR stock, worth $1,790. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49Holding current value
$1,790% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ARWR
# of Institutions
321Shares Held
99.5MCall Options Held
444KPut Options Held
568K-
Black Rock Inc. New York, NY15.7MShares$573 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.5MShares$567 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.6MShares$387 Million3.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$233 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$191 Million1.65% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $3.87B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...